REVOLUTIONARY HUMAN TUMOR HISTOCULTURE PLATFORM
Farcast Biosciences's unique and proprietary technology uses fresh human tumor samples cultured in a proven system that recreates TiME (Tumor immune MicroEnvironment) ex vivo
The culture system maintains morphology and viability while retaining native tumor architecture and immune components to enable evaluation of tumor response to drug treatment
TiME: Tumor immune MicroEnvironment
Recreating native human TiME ex vivo
Representing tumor heterogeneity
Preserving immune compartment
Retaining ECM and stromal component
CD8
Epcam
Farcast proprietary image
THE FARCAST ADVANTAGE
Extensive Hospital Network
Our networks include IRB approved cancer centers that provide fresh tumor samples from informed and consented patients to enable effective study of inter-patient heterogeneity
Wide Therapeutic Coverage
Our platform can evaluate therapeutic response across many drug categories including bi-specific antibodies, monoclonal antibodies, small molecules and oncolytic viruses in a short period of time
Comprehensive Assays
We offer a wide array of kinetic, and end-point assays for multi-dimensional analysis of mechanistic action and impact of therapeutic agents on tumor micro-environment in a cost effective manner
